Elon Musk only has until the end of this week to close the $44 billion acquisition deal with Twitter or go to court to face trial. Based on the reports, the 51-year-old billionaire needs to complete the transaction by 5 p.m. on Friday, Oct. 28.
According to CNN Business, the countdown comes after a series of delays since the deal was first agreed on in April. Twitter and Musk also engaged in legal battles as the latter expressed his intention to cancel the buyout at one point. The social media giant did not accept this decision and tried to push through with the deal by suing the Tesla and SpaceX founder.
It can be recalled that Musk agreed to buy Twitter six months ago for $54.20 per share, but a few weeks later, he wanted to scrap the deal. He gave some reasons for this move, and one was concerns over the alleged bots on the platform. He also cited the whistleblower’s claims against the company as another ground why he changed his mind.
Twitter eventually took legal action against Musk, and while preparing for the trial that was set on Oct. 17, Musk suddenly said he would move forward with the deal and would pay the originally agreed price. For this, the judge handling the case, Delaware Chancery Court Chancellor Kathaleen St. Jude McCormick, has set the deadline for the closure of the deal on Oct. 28. If Musk fails to do this, he will have to face the trial that was set for November.
Meanwhile, it was reported that South Korean financial service company, Mirae Asset, may help Musk in funding the Twitter deal. The company is said to be currently in talks with the billionaire and planning to commit around KRW300 billion or about $208 million, so Musk could finance the $44-billion buyout of Twitter.
A source told Reuters this week that the agreement with Mirae Asset may soon be finalized since the deadline for the transaction is approaching fast. Finally, this is not the first time that the Korean firm is investing in Musk’s businesses as it was revealed to have previously invested in SpaceX as well.


Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Thailand Inflation Remains Negative for 10th Straight Month in January
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



